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11Signaling in the Immunological
Synapse: Defining the Optimal Size
In this issue of Immunity, Varma et al. (2006) report
that in the synapses between T cells and planar bila-
yers, T cell receptor (TCR) proximal signaling takes
place in peripheral TCR-microclusters that form con-
tinually and that TCR signaling ceases when they fuse
with the central supramolecular activation cluster.
Molecular imaging techniques have provided new and
unexpected insights into T cell activation. Three-dimen-
sional immunofluorescence microscopy and live-cell
imaging of T cell-antigen presenting cell (APC) conju-
gates reveal that after cell conjugation, receptors and
intracellular proteins cluster into spatially segregated
domains within the immunological synapse (IS) (Monks
et al., 1998; Grakoui et al., 1999; Krummel and Davis,
2002). The T cell receptor (TCR)-CD3 clusters into a
‘‘central supramolecular activation cluster’’ (c-SMAC),
and the integrin LFA-1 forms a peripheral SMAC (p-
SMAC). Because the SMACs form only when the T cells
are productively activated, it was proposed that the
SMACs are essential for effective activation under phys-
iological conditions. However, the mechanisms of the
formation of such segregated SMACs and their precise
roles are still unknown. Nevertheless, an intact IS that
is sustained for several hours is required for effective
activation of the T cells (Huppa et al., 2003).
One of the remarkable features of T cell activation is
the extreme antigen (Ag) sensitivity of the T cells. T cells
can sense the presence of even one specific peptide-
MHC on an APC and are fully activated by as few as
ten specific peptide-MHC molecules on an APC (Irvine
et al., 2002). This extreme Ag sensitivity could result in
excessive activation and T cell death whenever T cells
interact with APCs expressing high densities of specific
peptide-MHC. However, an elegant model accountingfor the high Ag sensitivity and the protection from ex-
cessive activation has been proposed and states that
the c-SMAC serves as a regulator of TCR activation
(Lee et al., 2003). At low peptide-MHC concentrations,
clustering of the ligated TCR at the c-SMAC enhances
T cell activation, but at higher concentrations of pep-
tide-MHC, the c-SMAC would attenuate TCR activation
by modulating c-SMAC TCR activation or by enhancing
TCR degradation. If the c-SMAC attenuates TCR proxi-
mal signaling to prevent excessive activation, where
would the TCR continue to engage its Ag to sustain sig-
naling? This fascinating issue is addressed directly by
Varma et al. (2006) in this issue of Immunity.
To facilitate the study of the dynamic structure and
function of the IS in T-APC conjugates, Varma et al.
replaced cellular APCs with artificial surrogate APCs.
The supported planar lipid bilayers, which contain gly-
cosylphosphatidylinositol (GPI)-linked IEk (GPI -IEk)
and intercellular adhesion molecule 1 (GPI-ICAM-1) em-
bedded membrane proteins, have proven to be the
most relevant surrogate APCs for studying the IS (Gra-
koui et al., 1999). The ability of the embedded proteins
to diffuse laterally within the lipid bilayer enables the for-
mation of TCR clusters and SMACs in the T cells. Varma
et al. initially used total internal reflection fluorescence
microscopy (TIRFM) to follow TCR clustering and the
formation of the c-SMAC. They report that TCR micro-
clusters form rapidly and move independently toward
the center of the IS. During this movement small micro-
clusters fused to form larger clusters, and by 5–15 min
these larger clusters interconnected and became immo-
bilized at the center of the IS. This immobilized network
of TCR molecules was defined as the TCR-c-SMAC.
Varma et al. (2006) then address the location of TCR
proximal signaling during the later stages after the
c-SMAC was already formed. They report that TCR
microclusters continue to form after the formation of the
c-SMAC (>30 min). Interestingly, whereas the size of the
c-SMAC is linearly correlated with the density of the Ag,
the size of these microclusters remains quite constant
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12Figure 1. Model of TCR Signaling
Varma et al. suggest that three different types of TCR microclusters are formed sequentially in the IS. Initially (left), before TCR engagement,
LFA-1 binding to ICAM-1 triggers the formation of small nonsignaling TCR clusters. Upon TCR-MHC interaction (middle), larger stable TCR
microclusters form in a tyrosine kinase-independent but actin-dependent manner. These clusters exclude CD45 and are sites of TCR proximal
signaling. As these clusters move toward the center of the contact, they join to form a larger c-SMAC when TCR proximal signaling stops (right).(11–17 TCRs/cluster) over a 100-fold range of Ag densi-
ties. A previous report suggested that each microcluster
contains 40–130 TCR molecules (Yokosuka et al., 2005).
Here Varma et al. suggest that 11–17 TCRs/cluster may
be the smallest functional TCR unit that is needed to
sustain signaling, at least as measured by calcium
fluxing.
Because CD45 is generally excluded from sites where
TCR proximal tyrosine kinases are active, Varma et al.
investigated the location of CD45 in the microclusters
and the c-SMAC. They report that CD45 is excluded
from all early TCR microclusters but is included in most
c-SMACs. It is proposed that the inclusion of CD45 in
the c-SMAC may contribute to inactivation of the recep-
tor proximal tyrosine kinases. This inclusion of CD45 in
the c-SMAC is similar to the localized association of
CD45, and the TCR in the c-SMACs of T-APC conju-
gates during a brief inhibitory phase of the interaction
(Freiberg et al., 2002). However, unlike the planar bila-
yers, this inhibitory phase is terminated rapidly in T-
APC conjugates when CD45 is cleared from the c-SMAC
and is clustered mostly in the distal SMAC (d-SMAC).
To determine if the c-SMAC is a site of TCR down-
modulation, Varma et al. determined the location of
LBPA by imaging fixed and detergent-permeabilized
T cells. LBPA is an acidic phospholipid that is generated
in multi-vesicular bodies in late endosomes, where pro-
teins are sorted for membrane recycling and for degra-
dation. LBPA is found in the vicinity of most (60%)
c-SMACs but is not seen in TCR microclusters. This
supports the earlier model (Lee et al., 2003) proposing
that when the a T cell encounters an APC expressing
a large number of specific peptide-MHC molecules,
the c-SMAC can become a site of TCR down modulation
and degradation. The TCR-CD3 complex can be ubiqui-
tinated and targeted for degradation, or it can be phos-
phorylated on a receptor-sorting motif and targeted for
recycling. PKC-q, another c-SMAC protein, was recentlyshown to induce TCR down modulation by phosphory-
lating the recycling-motif selectively in engaged TCRs
(von Essen et al., 2006), but more imaging studies would
be needed to discriminate between internalized TCRs
destined for degradation and those destined for
recycling.
Varma et al. then employed an innovative experimen-
tal approach by using peptide-MHC antibodies to deter-
mine the differential contribution of the TCR microclus-
ters and the c-SMAC to signaling of calcium fluxing.
Treatment with MHC antibodies of T cells that formed
already stable c-SMACs blocked ongoing calcium flux-
ing within 2 min after the addition of the antibodies. This
treatment was shown by Varma et al. to block the forma-
tion of new TCR microclusters but had a minimal effect
on pre-existing microclusters and the c-SMAC. These
data suggest that calcium signaling requires the contin-
uous formation of new microcluters outside the c-SMAC.
Varma et al. also used the MHC-blocking Abs to treat
T cells expressing fluorescent Zap-70-GFP. They found
that this Ab treatment immediately blocked the forma-
tion of new Zap-70-GFP clusters, in a time frame that
is similar to that for the inhibition of calcium fluxing. Be-
cause the blocking Abs didn’t change the Zap-70 that
is associated with the c-SMAC, it was proposed that
the Zap-70 in the c-SMAC is not involved in signaling
for calcium elevation (Figure 1).
The mechanisms of TCR-microcluster formation are
unclear. It was previously reported that tyrosine kinase
inhibitors do not prevent the formation of microclusters.
Now Varma et al. show that latrunculin A, an actin-cyto-
skeleton inhibitor, prevents the formation of new clus-
ters and stops the movement of existing microclusters.
This inhibition is correlated with a reduction in the ongo-
ing intracellular calcium elevation. Thus, the actin cyto-
skeleton is involved in the formation of the TCR micro-
clusters, their translocation toward the c-SMAC, and
their ability to trigger calcium elevation. Remarkably,
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c-SMAC is disrupted by the actin inhibitor.
In summary, Varma et al. suggest that three different
types of TCR microclusters are formed sequentially in
the IS (Figure 1). Initially, before TCR engagement,
LFA-1 binding to ICAM-1 triggers the formation of small
nonsignaling TCR clusters. Upon TCR-MHC interaction,
larger stable TCR microclusters form in a tyrosine-ki-
nase-independent but actin-dependent manner. These
clusters exclude CD45 and are sites of TCR proximal
signaling. As these clusters move toward the center of
the contact, they join to form a larger c-SMAC when
TCR proximal signaling stops.
The studies by Varma et al. raise many fascinating new
questions. Activation of the kinases Lck and Fyn are
thought to initiate TCR signaling, but TCR-dependent re-
arrangement of the actin cytoskeleton and microcluster
formation are still induced in the presence of tyrosine ki-
nase inhibitors. What alternative early tyrosine-kinase-
independent pathways can be activated by the TCR?
TCR microclusters each containing11-17 Ag-MHC-
bound TCRs represent the smallest functional signaling
units. Under physiological conditions, APCs that ex-
press limiting numbers of specific peptide MHC mole-
cules still effectively activate T cells. Where is sustained
TCR signaling taking place in such T-APC conjugates,
and how would new TCR microclusters continually form
outsides the c-SMAC in such T-APC conjugates?
To consolidate the earlier model (Lee et al., 2003) with
that of Varma et al. (2006), it would be important to de-
termine the role of the microclusters and c-SMAC in
T-APC conjugates in the presence of limiting numbers
of specific Ag. It would be important to identify the
molecular mechanisms by which a T cell determines
whether to sustain TCR proximal activation in the
c-SMAC (few peptide-MHC) or in newly generated mi-
croclusters (abundant peptide-MHC). It would also be
important to determine if the stable c-SMAC may serve
as a platform for sustained signaling that involves more
distal proteins than that of TCR-associated molecules.
Signaling by PKC-q and other proteins that are involved
in relaying membrane proximal events to the nucleus
may continue in the c-SMAC for extended periods after
initial T-APC contact. One intriguing possibility is that
there are at least two roles for TCR proximal signaling.
The first is to initiate the formation of the IS and to setImmunity 25, July 2006 ª2006 Elsevier Inc. DOI 10.1016/j.immuni.2006.07.00
How Botryllus Chooses to Fuse
In Botryllus schlosseri, a highly polymorphic allore-
cognition system limits the potential for vascular fu-
sion by genetically dissimilar, adjacent colonies. In
this issue, Nyholm et al. (2006) uncover the nature of
the receptor that recognizes the products of the histo-
compatibility genes.in motion the subsequent downstream signaling origi-
nating from the IS and the c-SMAC. The sustained sig-
naling in the microclusters may be required mainly to
maintain an intact synapse, which is required for effec-
tive activation. Thus, the sustained TCR proximal sig-
naling may not trigger the same downstream effects
as the earlier TCR proximal signals.
As evident, the imaging of the IS has attracted a lot of
interest, and as for any new paradigm, many additional
studies would be needed to define its roles in T cell
activation. Because new imaging tools are being con-
stantly developed, it is likely that many of the outstand-
ing questions will be addressed in the future.
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The more complex a biological phenomenon is at the
system level, the greater the tendency of reductionistic
approaches to depart from physiological relevance. Im-
munological investigations of tissue transplantation,
which already represents a fundamentally unnatural,
multifactorial process involving antigen-presenting
cells, cell migration, MHC class I or class II, and T cell
specificity, provide no exception. In contrast to this
usual trend, Nyholm et al. (2006) report here their studies
